Encompass Health (EHC) Competitors

Universal Health Services pays an annual dividend of $0.80 per share and has a dividend yield of 0.5%. Encompass Health pays an annual dividend of $0.84 per share and has a dividend yield of 0.7%. Universal Health Services pays out 3.3% of its earnings in the form of a dividend. Encompass Health pays out 13.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has increased its dividend for 2 consecutive years. Encompass Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Universal Health Services has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Encompass Health has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

Encompass Health has a net margin of 10.01% compared to Universal Health Services' net margin of 8.42%. Universal Health Services' return on equity of 19.39% beat Encompass Health's return on equity.

Universal Health Services has higher revenue and earnings than Encompass Health. Universal Health Services is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

In the previous week, Universal Health Services and Universal Health Services both had 6 articles in the media. Encompass Health's average media sentiment score of 0.79 beat Universal Health Services' score of 0.42 indicating that Encompass Health is being referred to more favorably in the news media.

Universal Health Services currently has a consensus price target of $204.94, indicating a potential upside of 15.48%. Encompass Health has a consensus price target of $148.50, indicating a potential upside of 20.41%. Given Encompass Health's stronger consensus rating and higher possible upside, analysts clearly believe Encompass Health is more favorable than Universal Health Services.

86.1% of Universal Health Services shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 17.1% of Universal Health Services shares are held by insiders. Comparatively, 1.8% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

The Ensign Group pays an annual dividend of $0.26 per share and has a dividend yield of 0.2%. Encompass Health pays an annual dividend of $0.84 per share and has a dividend yield of 0.7%. The Ensign Group pays out 4.1% of its earnings in the form of a dividend. Encompass Health pays out 13.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Ensign Group has increased its dividend for 18 consecutive years and Encompass Health has increased its dividend for 2 consecutive years.

96.1% of The Ensign Group shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 4.0% of The Ensign Group shares are held by company insiders. Comparatively, 1.8% of Encompass Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

The Ensign Group presently has a consensus target price of $216.25, suggesting a potential upside of 25.87%. Encompass Health has a consensus target price of $148.50, suggesting a potential upside of 20.41%. Given The Ensign Group's higher possible upside, analysts clearly believe The Ensign Group is more favorable than Encompass Health.

In the previous week, The Ensign Group had 16 more articles in the media than Encompass Health. MarketBeat recorded 22 mentions for The Ensign Group and 6 mentions for Encompass Health. Encompass Health's average media sentiment score of 0.79 beat The Ensign Group's score of 0.26 indicating that Encompass Health is being referred to more favorably in the news media.

Encompass Health has a net margin of 10.01% compared to The Ensign Group's net margin of 6.90%. Encompass Health's return on equity of 18.08% beat The Ensign Group's return on equity.

Encompass Health has higher revenue and earnings than The Ensign Group. Encompass Health is trading at a lower price-to-earnings ratio than The Ensign Group, indicating that it is currently the more affordable of the two stocks.

The Ensign Group has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market. Comparatively, Encompass Health has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

Encompass Health has higher revenue and earnings than PACS Group. Encompass Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

In the previous week, PACS Group had 15 more articles in the media than Encompass Health. MarketBeat recorded 21 mentions for PACS Group and 6 mentions for Encompass Health. Encompass Health's average media sentiment score of 0.79 beat PACS Group's score of 0.26 indicating that Encompass Health is being referred to more favorably in the media.

Encompass Health has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, meaning that its stock price is 108% less volatile than the broader market.

Encompass Health has a net margin of 10.01% compared to PACS Group's net margin of 4.85%. PACS Group's return on equity of 29.55% beat Encompass Health's return on equity.

97.3% of Encompass Health shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Encompass Health presently has a consensus price target of $148.50, indicating a potential upside of 20.41%. PACS Group has a consensus price target of $58.80, indicating a potential upside of 35.35%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than Encompass Health.

Encompass Health has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

Encompass Health pays an annual dividend of $0.84 per share and has a dividend yield of 0.7%. Concentra Group Holdings Parent pays an annual dividend of $0.25 per share and has a dividend yield of 0.7%. Encompass Health pays out 13.7% of its earnings in the form of a dividend. Concentra Group Holdings Parent pays out 16.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has increased its dividend for 2 consecutive years. Encompass Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

97.3% of Encompass Health shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by insiders. Comparatively, 8.1% of Concentra Group Holdings Parent shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Encompass Health had 2 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 6 mentions for Encompass Health and 4 mentions for Concentra Group Holdings Parent. Encompass Health's average media sentiment score of 0.79 beat Concentra Group Holdings Parent's score of 0.24 indicating that Encompass Health is being referred to more favorably in the media.

Encompass Health has a net margin of 10.01% compared to Concentra Group Holdings Parent's net margin of 8.69%. Concentra Group Holdings Parent's return on equity of 47.81% beat Encompass Health's return on equity.

Encompass Health presently has a consensus target price of $148.50, suggesting a potential upside of 20.41%. Concentra Group Holdings Parent has a consensus target price of $39.40, suggesting a potential upside of 6.06%. Given Encompass Health's higher possible upside, equities analysts clearly believe Encompass Health is more favorable than Concentra Group Holdings Parent.

Encompass Health has higher revenue and earnings than Concentra Group Holdings Parent. Encompass Health is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.